CRS studies for CAR T cell therapy
29 May 2022In this application note, The Jackson Laboratory (JAX) reviews JAX’s cytokine release syndrome (CRS) evaluation capabilities. Download to see how a CRS study can help move your CAR T therapeutic into the clinic faster, safer, and more confidently.
Related Products
Request Quote for All Products
JAX® Mice and Services
The Jackson LaboratoryTake advantage of our large inventories of common inbred strains and the convenience of having your breeding and drug efficacy needs met by the leading experts in mouse modeling.